AIONCO
Dead / Abandoned — Abandoned — failure to respond (as of 15 Mar 2024)
What this means for you
This application is over — abandoned 12 Feb 2024. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 97646050
- Mark type
- Design + words
- Filed
- 24 Oct 2022
- Abandoned
- 12 Feb 2024
- Attorney of record
- Andrew J. Gray IV
Goods and services
- Class 005 — Pharmaceuticals: Medical testing products, namely, modified immune cells; Medical testing products, namely, modified immune cells for use in connection with various cancers with genetic treatments
- Class 009 — Scientific and electric apparatus: Downloadable software and mobile applications for genetic assessment and identification of cancer, cancer ailments, and cancer mutations for scientific, medical, diagnostic, treatment, and research purposes, for creating local databases of genomic sequences, cancer ailments, and cancer mutations for tracking, matching, searching, testing, aggregating, researching, and diagnosing cancer, cancer ailments, and cancer mutations, for creating, accessing, and using online databases of genomic sequences, cancer ailments, and cancer mutations for tracking, matching, searching, testing, aggregating, researching, and diagnosing cancer, cancer ailments, and cancer mutations, for recording, analyzing, storing, manipulating and organizing genetic and molecular data, and for providing access to multiple online databases that contain aggregated results of molecular biology testing and genotyping; medical testing products, namely, downloadable vaccination test forms
- Class 010 — Medical apparatus: Medical testing and treatment products in the form of treatment therapies, namely, apparatus for medical diagnosis, drug delivery apparatus and genetic delivery apparatus all for various cancers with genetic treatments and specimen collection tubes and containers for collecting patient specimens, namely, blood, urine, saliva, and tissue, for genomic sequencing and for detection of gene mutations, gene expression profiles or other molecular indicators or markers associated with cancer or risk of developing cancer; Medical testing and treatment product kits containing blood specimen collection tubes and containers for collecting patient blood specimens for genomic sequencing and detection of gene mutations, gene expression profiles or other molecular indicators or markers associated with cancer or risk of developing cancer modified immune cells and treatment therapies, and also containing modified immune cells, treatment therapies, test forms, mailing materials and user information inserts
- Class 016 — Paper goods and printed matter: Medical testing and treatment products, namely, printed test forms and printed user information inserts for medical products; Medical testing products, namely, printed vaccination test forms
- Class 042 — Scientific and technological services: Providing online non-downloadable software and software programs for genetic assessment and identification of cancer, cancer ailments, and cancer mutations for scientific, medical, diagnostic, treatment, and research purposes, for creating online databases of genomic sequences, cancer ailments, and cancer mutations for tracking, matching, searching, testing, aggregating, researching, and diagnosing cancer, cancer ailments, and cancer mutations, for creating, accessing, and using online databases of genomic sequences, cancer ailments, and cancer mutations for tracking, matching, searching, testing, aggregating, researching, and diagnosing cancer, cancer ailments, and cancer mutations, for recording, analyzing, storing, manipulating and organizing genetic and molecular data, and for providing access to multiple online databases that contain aggregated results of molecular biology testing and genotyping
- Class 044 — Medical, beauty and agricultural services: Providing medical diagnostic and treatment services, namely, tumor detection in the form of a liquid biopsy; medical diagnostic and treatment services in the nature of tumor analysis, diagnosis, and identification in the form of sequenced tissue identification, and tumor medical treatment therapy in the form of identification of appropriate combination of mutations for targeted cancers and identification of appropriate treatments targeted for those combination of mutations via modified T-Cells in the form of other treatments to inhibit expressions of those combination of mutations and to modify one or more of the mutations in the combination
Owner
- Avellino Lab USA, Inc., Menlo Park, CA, US
Prosecution history
- 15 Mar 2024 — ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
- 15 Mar 2024 — ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
- 10 Nov 2023 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
- 10 Nov 2023 — APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
- 11 Aug 2023 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 11 Aug 2023 — NON-FINAL ACTION E-MAILED
- 11 Aug 2023 — NON-FINAL ACTION WRITTEN
- 07 Aug 2023 — ASSIGNED TO EXAMINER
- 09 Nov 2022 — NOTICE OF DESIGN SEARCH CODE E-MAILED
- 08 Nov 2022 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 27 Oct 2022 — NEW APPLICATION ENTERED